AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Auraglik-M40 Tablet

Prescription Icon
Prescription Required

Marketer

Aura Lifecare Private Limited

Salt Composition

Gliclazide (40mg) + Metformin (500mg)

Overview Auraglik-M40 Tablet

Diabetol Duo-40 tablets are classified as antidiabetic medications, combining two drugs to manage type 2 diabetes in adults. This dual-action formula helps regulate blood glucose. Diabetol Duo-40 should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar response. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision loss, neuropathy, and limb amputation. Remember, this medication complements a comprehensive diabetes management plan involving diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Common side effects include hypoglycemia (low blood sugar), characterized by sweating, dizziness, headache, and tremors; constipation; and vomiting. Carrying a fast-acting glucose source (e.g., sugary snacks or juice) is vital to manage hypoglycemia, which can be exacerbated by alcohol consumption. Other possible side effects encompass altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe liver or kidney disease. Individuals with a history of heart disease should consult their doctor before initiating treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring and periodic blood tests to assess blood cell counts and liver function are recommended.

Uses of Auraglik-M40 Tablet

Adult-onset diabetes

Major Benefits of Auraglik-M40 Tablet:

Consume this medication according to your physician's prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Auraglik-M40 Tablet with food.

Common Side effects of Auraglik-M40 Tablet:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Dizziness
  • Diarrhea
  • Upper respiratory tract infection
  • Nausea
  • Flatulence
  • Constipation

How to use Auraglik-M40 Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Auraglik-M40 Tablet with a meal.

How Auraglik-M40 Tablet works:

Gliclazide and metformin are combined in Auraglik-M40, an oral antidiabetic medication.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Auraglik-M40 Tablet is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Auraglik-M40 tablets during pregnancy poses a confirmed risk to the unborn child. Therefore, it's contraindicated. In exceptional circumstances involving life-threatening conditions, a physician might prescribe it if the potential benefits outweigh the known dangers. Always seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Auraglik-M40 Tablet while breastfeeding is likely inadvisable. Available data from human studies indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Impaired driving is possible with severely low or high blood sugar levels. Refrain from driving if you experience such symptoms.

KidneyKidneyCAUTION

Patients with kidney impairment should use Auraglik-M40 Tablets cautiously, potentially requiring dosage modification. Consultation with a physician is essential. The medication is contraindicated in those with severe kidney disease. Regular monitoring of kidney function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Auraglik-M40 Tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. For individuals with mild to moderate hepatic dysfunction, Auraglik-M40 Tablets are typically initiated at a low dosage; however, their use is contraindicated in those with severe liver disease.

What if you forget to take Auraglik-M40 Tablet :

Should you forget a dose of Auraglik-M40 Tablet, administer it at your earliest convenience. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Auraglik-M40 Tablet

LabelValue
Potential for Dependence None.
Type of Medication Medication for diabetes

FAQs on Auraglik-M40 Tablet

A combination medication, Auraglik-M40 Tablet contains gliclazide and metformin, and is indicated for managing type 2 diabetes mellitus in adults. This treatment improves blood sugar control when combined with a suitable diet and exercise regimen. Gliclazide enhances insulin secretion from the pancreas, thus reducing blood glucose. Metformin acts by decreasing hepatic glucose production and increasing insulin responsiveness. This dual-drug formulation is unsuitable for individuals with type 1 diabetes.
Aruglik-M40 Tablet may cause common adverse reactions such as low blood sugar (hypoglycemia), changes in taste perception, nausea, abdominal discomfort, loose stools, headache, and upper respiratory infections. Rare but potentially severe side effects, including lactic acidosis, are also possible. Prolonged treatment may result in vitamin B12 deficiency.
Auraglik-M40 Tablet can indeed lead to low blood sugar (hypoglycemia). This may manifest as nausea, headache, irritability, hunger pangs, sweating, dizziness, a rapid pulse, and feelings of anxiety or trembling. The risk increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other diabetes medications. Consequently, consistent blood glucose monitoring is crucial. Always carry a readily available source of glucose, such as glucose tablets, honey, or fruit juice.
Indeed, Auraglik-M40 Tablet use may result in lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this is an uncommon adverse reaction to metformin. Its occurrence is minimized by avoiding its prescription for individuals with pre-existing kidney impairment, the elderly, or those consuming substantial alcohol. Lactic acidosis symptoms can manifest as muscle aches or weakness, vertigo, fatigue, cold extremities, respiratory distress, nausea, emesis, abdominal discomfort, or bradycardia. Should these symptoms appear, discontinue Auraglik-M40 Tablet immediately and seek medical attention.
Prolonged Auraglik-M40 Tablet use can indeed lead to vitamin B12 deficiency. This is because the medication impedes the stomach's absorption of vitamin B12. Untreated deficiency may manifest as anemia, neurological issues including tingling and numbness in extremities, weakness, bladder dysfunction, cognitive changes, and impaired coordination. Preventive measures, suggested by some studies, include supplemental vitamin B12 at least annually.
Patients with hypersensitivity to any ingredient or inactive component within Auraglik-M40 Tablet should not use this medication. Its use is also contraindicated in individuals with moderate to severe renal impairment or pre-existing metabolic acidosis, such as diabetic ketoacidosis.
Combining Auraglik-M40 Tablet with alcohol is unsafe. This combination can reduce blood sugar to dangerously low levels (hypoglycemia) and heighten the risk of lactic acidosis.
Auraglik-M40 tablets contain gliclazide and metformin, two medications used together to manage type 2 diabetes mellitus in adults. The combination enhances blood sugar control when combined with a healthy diet and regular physical activity. Gliclazide stimulates insulin secretion from the pancreas to reduce blood glucose. Metformin reduces hepatic glucose production and increases insulin sensitivity. This dual medication is unsuitable for treating type 1 diabetes.
Auraglik-M40 Tablet can cause several common adverse reactions, such as low blood sugar (hypoglycemia), taste changes, nausea, abdominal pain, diarrhea, headache, and upper respiratory infections. Rare but potentially serious side effects, including lactic acidosis, may also occur. Prolonged administration may result in vitamin B12 deficiency.
Auraglik-M40 Tablets can induce hypoglycemia, characterized by low blood sugar. Manifestations of low blood sugar include nausea, headache, irritability, hunger pangs, sweating, dizziness, tachycardia, and feelings of anxiety or tremor. The risk increases with missed or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Consequently, consistent blood glucose monitoring is crucial. Carrying readily available glucose sources, such as glucose tablets, honey, or fruit juice, is advisable.
Aruglik-M40 Tablet use carries a risk of lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this is an uncommon side effect of metformin. It's best avoided in individuals with kidney impairment, the elderly, or those consuming significant alcohol. Symptoms can manifest as muscle aches or weakness, lightheadedness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, or bradycardia. Should these symptoms appear, discontinue Aruglik-M40 Tablet immediately and seek medical attention.
Indeed, prolonged Auraglik-M40 Tablet use can lead to vitamin B12 insufficiency. This deficiency arises from the medication's disruption of vitamin B12 absorption in the gastrointestinal tract. Left unaddressed, this can result in anemia, neurological complications, including paresthesia in the extremities, generalized weakness, urinary dysfunction, cognitive impairment, and gait instability. To mitigate these risks, supplemental vitamin B12 intake, at a minimum annually, is recommended by some studies.
Patients with hypersensitivity to any ingredient or inactive component within Auraglik-M40 Tablet should not use this medication. Similarly, its use is contraindicated in individuals with moderate to severe renal impairment or pre-existing metabolic acidosis, such as diabetic ketoacidosis.
Consuming alcohol concurrently with Auraglik-M40 Tablets is unsafe. This combination risks exacerbating hypoglycemia and raises the likelihood of lactic acidosis.
Auraglik-M40 Tablet
76
MRP 92
17% off